<DOC>
	<DOCNO>NCT01497327</DOCNO>
	<brief_summary>This study conduct Hepatitis C positive patient determine whether pharmacodynamic effect PSI-7977 PSI-352938 similar HCV-infected patient normal hepatic function , may allow inclusion patient cirrhosis vary degree hepatic dysfunction future clinical study .</brief_summary>
	<brief_title>Open-Label Hepatic Impairment Study</brief_title>
	<detailed_description>This study design per Food Drug Administration ( FDA ) guidance patient impaired hepatic function ass influence hepatic impairment PK pharmacodynamics ( PD ) PSI-7977 PSI-352938 This study conduct Hepatitis C positive patient ascertain whether PD effect PSI-7977 PSI-352938 similar HCV-infected patient normal hepatic function , may allow inclusion patient cirrhosis vary degree hepatic dysfunction future clinical study . Data subject participate P2938-0212 study ( PSI-352938 MAD ) use control group . These subject document non-cirrhotic subject normal hepatic function . Hepatitis C Virus ( HCV ) Genotypes 1-6 enrolled study .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Hepatic impair Males female nonchildbearing potential age &gt; 18 year Chronic HCVinfection Na√Øve direct act antiviral ( DAA ) treatments chronic HCV infection . Documented Cirrhosis Prior PEG/RBV null responder . Unstable cardiac disease , recent Myocardial infarction , family history QTc prolongation unexplained cardiac arrest . Positive test Screening antiHAV IgM Ab , HBsAg , antiHBc IgM Ab , antihuman immunodeficiency virus ( HIV ) Ab . History clinically significant medical condition associate chronic liver disease Any current sign symptom severe hepatic encephalopathy History gastric esophageal variceal bleed varix adequately treated medication surgical procedure Prior placement portosystemic shunt History hepatorenal , hepatopulmonary syndrome . Active spontaneous bacterial peritonitis . Use medication associate QT prolongation within 28 day prior dose . Current Hypotension History Torsades de Pointes , evidence active suspected cancer , history malignancy , Abnormal hematological biochemical parameter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>HEPATITIS C , CHRONIC</keyword>
	<keyword>HCV</keyword>
	<keyword>hepatic impairment</keyword>
</DOC>